Beijing Orders Officials to Downplay Pneumonia: Insider | China In Focus
⭕ Watch the full episode on EpochTV 👉https://ept.ms/AnotherVirusCoverup_YT
⭕️ Sign up for our NEWSLETTER and stay in touch👉https://www.ntd.com/newsletter.html
🔴 THE FINAL WAR is a documentary that uncovers the Chinese Communist Party’s 100-year plot to defeat America.👉👉https://ept.ms/3V3NfV9
🔵 Sekur (promo code: Tiffany) 👉https://ept.ms/3yW0Wul
🔵 A Documentary by The Epoch Times, reveals the truth that has been hidden from the American people.👉 https://ept.ms/3cTR1zF
🔥 BEST OFFER EVER 👉https://ept.ms/1For2Months-Tiffany
-
The global spotlight is returning to China. A secret directive from Beijing on pneumonia reporting brings its medical transparency into question yet again.
How does the current outbreak of "undiagnosed pneumonia" with unusual symptoms in China compare to COVID-19? We take a look at expert insights.
An influence memo from the Chinese Communist Party was exposed by U.S. lawmakers. How do the regime's tactics operate in America?
Washington has promised a new round of mid-range missiles to the Indo-Pacific region next year. Officials say the weapons will keep Beijing's forces away from Taiwan.
00:00 Intro
00:59 Beijing Orders Officials to Downplay Pneumonia: Insider
04:11 How Should We Read the Rise of Pneumonia in China?
06:39 U.S. to Deploy Missiles to Pacific Amid China Threat
08:20 S. Korea Joins NATO's Cyber Defense Exercise
08:55 China Trying to Recruit Canadian Gov't Workers: Report
09:33 Reps. Warn of Mao Zedong's 'Magic Weapon'
11:45 Canadian Colleges Ban WeChat from School Devices
13:21 China Fighting Against Supply Chain Decoupling
14:24 China Launches Probe into Wealth Manager Zeg
15:14 Evergrande Subsidiary Sues Parent Company
15:40 China's SHEIN Files to List on U.S. Stock Market
---------
💎 Support our work: https://donorbox.org/china-in-focus
⭕️ Subscribe YouTube👉https://www.youtube.com/channel/UCBOqkAGTtzZVmKvY4SwdZ2g?sub_confirmation=1
⭕️ Get NTD on TV 👉 http://www.NTD.com/TV
-------------------------------------------------
-------------------------------------------------
© All Rights Reserved.